[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350610-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350610-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tumour-location-and-mismatch-repair-status-impact-gene-expression-profiles-associated-with-lymph-node-metastases-in-t1-colon-cancers","Tumour location and mismatch repair status impact gene expression profiles associated with lymph node metastases in T1 colon cancers","","Accurate identification of early (T1) colon cancer patients with lymph node metastases remains challenging, and current approaches risk substantial overtreatment. This retrospective translational study analyzed intratumoural gene expression in 24 surgically treated T1 colorectal cancer patients to test whether tumour location and mismatch repair (MMR) status shape gene expression profiles. Tumour location and MMR status significantly influenced intratumoural gene expression in patients with and without lymph node metastases, improving differential gene detection.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tumour-location-and-mismatch-repair-status-impact-gene-expression-profiles-associated-with-lymph-node-metastases-in-t1-colon-cancers/350610/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tumour-location-and-mismatch-repair-status-impact-gene-expression-profiles-associated-with-lymph-node-metastases-in-t1-colon-cancers/350610.png","ImageObject",300,407,{"name":42,"@type":43},"Anna Hans","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is identifying lymph node metastases in T1 colon cancer clinically difficult?","Question",{"text":63,"@type":64},"Lymph node metastases occur in a minority of T1 colon cancer patients, and current strategies have limited accuracy, leading to substantial overtreatment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What does mismatch repair (MMR) status contribute to gene expression differences?",{"text":68,"@type":64},"MMR status is an important biological factor; mismatch repair–deficient cancers are associated with higher tumour mutational burden and immune responses, which can influence intratumoural gene expression.",{"name":70,"@type":61,"acceptedAnswer":71},"How did tumour location and MMR status affect differential gene detection in the study?",{"text":72,"@type":64},"Side-specific and MMR status-specific analyses identified a higher number of differentially expressed genes with lower false discovery rates compared with analyses across all patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350610,1790137740,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892332657,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nTumour location and mismatch repair status impact gene expression profiles associated with lymph node metastases inT1 colon cancers  \nAnders L. Ebbehøj1, Lars N. Jørgensen1, Deepthi Chiranth2, Linea C. Melchior2, Thomas Litman3, Peter-Martin Krarup1 & Henry G. Smith1,4􀀍  \nAccurate identification of which patients with early (T1) colon cancer (CC) have lymph node metastases (LNM) is a major challenge. Current strategies have limited accuracy, resulting in overtreatment of> 80% of patients. Whilst gene expression profiles (GEPs) have shown promise in identifying patients with LNM in early studies, these have not become a routine part of clinical practice. A limitation of these GEPs is that they are generic and so agnostic of other factors that could influence gene expression, such as tumour location and mismatch repair (MMR) status. In a retrospective translational study of 24 patients who underwent surgery forT1 CC, we demonstrate that both tumour location and MMR status have a significant impact on intratumoural gene expression. This impact was seen inpatients with and without LNM. When compared to analyses of all patients, side-specific and MMR status-specific analyses revealed a higher number of differentially expressed genes with lower false discovery rates. Several interesting candidate genes for LNM were identified, including AHNAK, ATG12 and DMBT1. These findings demonstrate the influence of tumour location and MMR status on intratumoural gene expression inT1 CC and highlights the need to account for these factors when developing GEPs for clinical translation.  \nKeywords Colon cancer, Lymph node metastases, Gene expression profiles  \nSince the introduction of national bowel cancer screening programmes, the proportion of patients diagnosed with early (or T1) colon cancer (CC) has risen1–3. Determining the optimal management for this expanding group of patients is a major challenge. T1 CCs are limited to the innermost layers of the bowel wall and are often diagnosed unexpectedly after removal of a presumed benign polyp during colonoscopy4. This presents a clinical dilemma, where one must decide whether further treatment is necessary. Despite the early stage of disease, lymph node metastases (LNM) are found in up to 10–15% of patients with T1 CC5–7. These patients require further surgery (or completion colectomy) to be cured, where the tumour-bearing segment of bowel is removed along with its adjacent lymph nodes. However, LNM are absent in > 80% patients, who will already have been cured by their local excision and so in principle require no further treatment4.  \nMaking the correct decision in this context is crucial. On the one hand, there is the need to avoid undertreating patients with occult LNM. The presence of LNM has implications not only for a patient’s prognosis, leading toa transition from Stage I to Stage III disease, but also for their treatment, with adjuvant chemotherapy currently recommended as standard for patients with LNM8. On the other hand, there is also a need to limit overtreatment of the majority of patients with T1 CC in whom LNM are absent. Major surgery for CC is associated with considerable risks, not only for post-operative complications but also for long-term functional adverse effects that can significantly reduce quality of life9–11.  \n1Department of Pathology, Center of Diagnostic Investigation, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. 2Department of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark. 3Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. 4Digestive Disease Center, Copenhagen University Hospital- Bispebjerg, Entrance 8, ground floor, Nielsine Nielsens Vej 11, 2400 Copenhagen, NV, Denmark. 􀀍 email: [henry.george.smith@regionh.dk](henry.george.smith@regionh.dk)  \nThe current ","cbCaisqXQGje8lSD","https://ap.wps.com/l/cbCaisqXQGje8lSD","pdf",3592712,11,"English","# Tumour location, MMR status, and gene expression in T1 colon cancer\n## Clinical challenge of identifying lymph node metastases\n## Limitations of current histopathological risk stratification\n## Rationale for gene expression profiles\n## Study approach and key candidate genes","[{\"question\":\"Why is identifying lymph node metastases in T1 colon cancer clinically difficult?\",\"answer\":\"Lymph node metastases occur in a minority of T1 colon cancer patients, and current strategies have limited accuracy, leading to substantial overtreatment.\"},{\"question\":\"What does mismatch repair (MMR) status contribute to gene expression differences?\",\"answer\":\"MMR status is an important biological factor; mismatch repair–deficient cancers are associated with higher tumour mutational burden and immune responses, which can influence intratumoural gene expression.\"},{\"question\":\"How did tumour location and MMR status affect differential gene detection in the study?\",\"answer\":\"Side-specific and MMR status-specific analyses identified a higher number of differentially expressed genes with lower false discovery rates compared with analyses across all patients.\"}]","Tumour location and mismatch repair status impact gene expression profiles associated with lymph node metastases in T1 colon cancers | PDF",1790089879,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39521967c4cfa856a211674529a5f51f.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ca2de1b420d62e82d65ed19b91e74d4.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c22fde5e42f08bf3182e22ef1d04863.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7dfb387f5ca6b28d4ebda31190d445a8.webp",980,1287]